Legal Representation
Attorney
Stewart J Bellus
USPTO Deadlines
Next Renewal Deadline
1135 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-08-16)
Due Date
August 16, 2028
Grace Period Ends
February 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 16, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 16, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 14, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jul 14, 2022 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| May 10, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 10, 2022 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED |
| May 10, 2022 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
| Mar 15, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 15, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 23, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 9, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 8, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 8, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 8, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 3, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 3, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Feb 3, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 26, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 23, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 27, 2021 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Sep 27, 2021 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Sep 23, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, preparations for cardiovascular treatment, gastroenteric treatment, for the central nervous system; antibacterial substances for medical purposes; antitumoral drugs, namely, pharmaceutical preparations for suppressing tumors; veterinary preparations, namely, preparations for cardiovascular treatment, gastroenteric treatment, for the central nervous system; antibacteric, antitumoral drugs for livestock and domestic animal; dietetic foods adapted for medical use; nutritional supplements
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the term "indena" in black, to the right of a design of a black curved interrupted line reproducing the stylized letters "I", "N" and "D", marking off a closed space inside of which appears a green quadrilateral. The color white represents background areas and is not claimed as a feature of the mark.
Color Claim
The color(s) black and green is/are claimed as a feature of the mark.
Classification
International Classes
005